Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TriSalus Life Sciences, Inc. | CEO AND PRESIDENT, Director | Common Stock | 365K | Feb 13, 2024 | Direct | ||
TriSalus Life Sciences, Inc. | CEO AND PRESIDENT, Director | Employee Stock Option (right to buy) | 289K | Feb 13, 2024 | Direct | ||
Kura Oncology, Inc. | Director | Option to purchase common stock | 26K | Jun 5, 2024 | Direct | ||
Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25K | Jun 20, 2024 | Direct | ||
Prometheus Biosciences, Inc. | Director | Common Stock | 0 | $108.42 | Jun 16, 2023 | Direct | |
Prometheus Biosciences, Inc. | Director | Stock Option (right to buy) | 0 | Jun 16, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OMGA | Omega Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
KURA | Kura Oncology, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
TLSI | TriSalus Life Sciences, Inc. | Feb 13, 2024 | 2 | $0 | 4 | Feb 14, 2024 | CEO AND PRESIDENT, Director |
TLSI | TriSalus Life Sciences, Inc. | Aug 14, 2023 | 1 | $0 | 4 | Aug 15, 2023 | CEO and President, Director |
TLSI | TriSalus Life Sciences, Inc. | Aug 10, 2023 | 0 | $0 | 3 | Aug 15, 2023 | CEO and President, Director |
RXDX | Prometheus Biosciences, Inc. | Jun 16, 2023 | 3 | $0 | 4 | Jun 16, 2023 | Director |
OMGA | Omega Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
KURA | Kura Oncology, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
RXDX | Prometheus Biosciences, Inc. | May 19, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
KURA | Kura Oncology, Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 23, 2022 | Director |
OMGA | Omega Therapeutics, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
RXDX | Prometheus Biosciences, Inc. | May 19, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
OMGA | Omega Therapeutics, Inc. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director |
KURA | Kura Oncology, Inc. | Jun 22, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Director |